The Economic Times
English EditionEnglish Editionहिंदी संस्करण
| E-Paper
Search
+

    Moderna vaccine being reviewed for WHO emergency listing: WHO spokesman

    Synopsis

    "Moderna is being reviewed at the TAG (technical advisory group) meeting today," WHO spokesman Christian Lindmeier said in reply to a query. A decision on the U.S. drugmaker's vaccine was expected in one to four days, he said.

    Reuters
    So far COVID-19 vaccines made by Pfizer, AstraZeneca and Johnson & Johnson have already received WHO approval, which is a signal to national regulatory authorities on a product's safety and efficacy.
    Moderna's COVID-19 vaccine is being reviewed on Monday by technical experts for possible WHO emergency use listing, a World Health Organization spokesman told Reuters.

    "Moderna is being reviewed at the TAG (technical advisory group) meeting today," WHO spokesman Christian Lindmeier said in reply to a query. A decision on the U.S. drugmaker's vaccine was expected in one to four days, he said.

    So far COVID-19 vaccines made by Pfizer, AstraZeneca and Johnson & Johnson have already received WHO approval, which is a signal to national regulatory authorities on a product's safety and efficacy.
    (Catch all the Business News, Breaking News Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    The Economic Times

    Stories you might be interested in